During the past decade, ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg" are "Multiple Myeloma" (2 trials), "Chronic Myeloid Leukemia" (1 trials) and "Myeloproliferative Neoplasms" (1 trials). Many other conditions were trialed in "ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg" in a lesser frequency.

Most popular intervention types in "ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Bortezomib" (2 trials), "Dexamethasone" (2 trials), "Lenalidomide" (2 trials), "Isatuximab" (1 trials) and "Nilotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg" are 4 trials for "All" genders.

Currently, there are NaN active trials in "ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg has several departments that took part in Clinical trials: "MarienHospital Onkologische Praxis" - 2 trials